Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QMF149 in mild to moderate asthma
NCT00605306Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2008
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of indacaterol, mometasone in asthma, sponsored by Novartis. Started Jan 2008; status: completed.
02
Drugs
indacaterolmometasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00605306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00605306.